Amesite
AMST
7 hedge funds and large institutions have $323K invested in Amesite in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
98% more capital invested
Capital invested by funds: $163K → $323K (+$160K)
1.04% more ownership
Funds ownership: 2.47% → 3.51% (+1%)
0% more funds holding
Funds holding: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$104K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.34K |
| 3 |
JP Morgan Chase
New York
|
+$1.95K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2.79K |
| 2 |
PMFA
Plante Moran Financial Advisors
Southfield,
Michigan
|
-$326 |
AMST Hedge Fund Activity: Q2 2023 in Review
7 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Amesite (AMST) for Q2 2023, worth a combined $323K — up 98% from $163K a quarter earlier.
Fund positioning in AMST was balanced in Q2 2023: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, adding an estimated $104K. The largest seller was UBS Group, exiting entirely with an estimated $2.79K sold.
- 7 institutional investors held Amesite (AMST) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $323K of Amesite stock for Q2 2023, up 98% quarter-over-quarter.
- 2 funds opened new Amesite positions in Q2 2023 and 2 closed out, a net change of 0 holders.
- The largest Amesite buyer in Q2 2023 was Vanguard Group, an estimated $104K added.
- The largest Amesite seller in Q2 2023 was UBS Group, an estimated $2.79K sold.
Based on aggregated 13F filings for Q2 2023.